Monoclonal Antibody Treatment By Eli Lilly Found To Cut Risk of Serious COVID19, Drugmaker Reports . El Tratamiento con Anticuerpos Monoclonales por Eli Lilly ha Comprobado Reducir el Riesgo de COVID-19 Grave, Informa Eli Lilly.